Trinity Biotech (TRIB) Amortizatization of Intangibles (2021 - 2024)
Trinity Biotech (TRIB) posted quarterly Amortizatization of Intangibles of $109000.0 for Q4 2024, down 76.3% year-on-year from $460000.0 in Q1 2024, and up 32148.52% on a QoQ basis from $338.0 in Q3 2024.
Trinity Biotech (TRIB) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Amortizatization of Intangibles for 4 consecutive years, with $109000.0 the latest figure, recorded in Q4 2024.
- Quarterly Amortizatization of Intangibles fell 76.3% year-over-year to $109000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $110083.0 (down 76.09% YoY) and the FY2025 annual result came in at $1.4 million, up 16.39% from the prior year.
- Amortizatization of Intangibles improved to $109000.0 in Q4 2024 per TRIB's latest filing, from $338.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for TRIB reached as high as $460000.0 in Q4 2023 and fell as low as $56.0 in Q3 2023.
- A 4-year average of $98463.3 and a median of $338.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles slumped 99.98% — and 2024, when it jumped 503.57%.
- Year by year, Amortizatization of Intangibles stood at $228000.0 in 2021, then retreated by 5.7% to $215000.0 in 2022, then surged by 113.95% to $460000.0 in 2023, then sank by 76.3% to $109000.0 in 2024.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $109000.0, $338.0, and $218.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 338.00 |
| Sep 30, 2024 | 338.00 |
| Jun 30, 2024 | 218.00 |
| Jun 30, 2024 | 218.00 |
| Mar 31, 2024 | 527.00 |
| Mar 31, 2024 | 527.00 |
| Dec 31, 2023 | 460,000.00 |
| Dec 31, 2023 | 460,000.00 |
| Sep 30, 2023 | 56.00 |
| Sep 30, 2023 | 56.00 |
| Jun 30, 2023 | 179.00 |
| Jun 30, 2023 | 179.00 |
| Mar 31, 2023 | 251.00 |
| Mar 31, 2023 | 251.00 |
| Dec 31, 2022 | 215,000.00 |
| Dec 31, 2022 | 215,000.00 |
| Sep 30, 2022 | 266,000.00 |
| Sep 30, 2022 | 266,000.00 |